Stock Screener App

Gratuito - Play StoreApp Store

Installare Installare

LEGN

$21.632.51%0.53

Legend Biotech Corp Adr (LEGN)

Date: O: H: L: C: Vol:

Legend Biotech Corp Adr Borsa (LEGN) Ultime notizie

NBTX Stock Price, Quote & News - Syfe

Legend Biotech Stock Clears Key FDA Hurdle With LB2501 IND Approval - Simply Wall Street

Zai Lab Limited (ZLAB) Stock Price, News, Quote & History - Yahoo! Finance Canada

FDA Grants IND Approval to Legend Biotech for LB2501 Dual-Targeting CAR-T Therapy - Kalkine Media

Learn Why The Bull Case For Legend Biotech Stock Could Change Following Five Year CARVYKTI Data - Simply Wall Street

Legend Biotech Director Corazon Sanders Sells 27,370 Shares at $9.46 Average Price - Kalkine Media

Legend Biotech Corporation (LEGN) Stock Price, News, Quote & History - Yahoo! Finance Canada

Legend Biotech (NasdaqGS:LEGN) Stock Forecast & Analyst Predictions - Simply Wall Street

Legend Biotech | 144: Notice of proposed sale of securities pursuant to Rule 144 - Moomoo

Form 4 Legend Biotech Corp For: 29 September By Investing.com - Investing.com Nigeria

Form 4 Legend Biotech Corp For: 29 September By Investing.com - Investing.com UK

Can Legend Biotech (LEGN) Turn Cell Therapy Scale Into Compounding Wealth? - Yahoo Finance

A share grant led to a tax-related sale: Legend Biotech (LEGN) CFO received 19,676 shares and sold 5,430. - Stock Titan

Legend Biotech CFO Carlos E. Santos Reports Share Acquisition and Sale on September 21, 2026 - Kalkine Media

Form 4 Legend Biotech Corp For: 23 September By Investing.com - Investing.com Canada

Data on five-year remission with a myeloma treatment will be presented in Scotland - Stock Titan

Legend Biotech (LEGN) Falls 3.5% to $19.78, Pressing Down on Key Support as CAR-T Sector Weakens - Volume Breakout Ideas - https://www.dars.gov.et/

Legend Biotech (LEGN) Falls 3.5% to $19.78, Pressing Down on Key Support as CAR-T Sector Weakens - Elliott Wave Entry - dars.gov.et

Stevanato Group S.p.A. (STVN) Stock Price & News - Syfe

H.C. Wainwright reiterates Legend Biotech stock rating at buy - investing.com

Legend Biotech (LEGN) Institutional Ownership 2026 - MarketBeat

Legend Biotech (LEGN) Declines 2.9% as Shares Approach Key $19.65 Support - Passive Flow - siam.in

Legend Biotech (LEGN) Declines 2.9% as Shares Approach Key $19.65 Support - Reversal Trade - dars.gov.et

Legend (LEGN) Q2 2026 Results: The Available Earnings Metric Delivers a Beat on the Day; After Earnings: Shares Move Lower 4.03% in Latest Trading - Debt Analysis Report - https://www.dars.gov.et/

Legend (LEGN) Quarterly Results: EPS Clears the Reported Estimate at the Close; Latest Reaction: Shares Rise 3.10% for the Current Session - Revenue Warning Signal - dars.gov.et

Legend (LEGN) Quarterly Results: EPS Clears the Reported Estimate at the Close; Latest Reaction: Shares Rise 3.10% for the Current Session - Earnings Momentum Score - dars.gov.et

Legend (LEGN) Quarterly Results: EPS Clears the Reported Estimate at the Close; Latest Reaction: Shares Rise 3.10% for the Current Session - EPS Surprise History - dars.gov.et

Legend (LEGN) Quarterly Results: EPS Clears the Reported Estimate at the Close; Latest Reaction: Shares Rise 3.10% for the Current Session - Earnings Beat Alert - www.dars.gov.et

Legend Biotech (NASDAQ: LEGN) targets 19.1M new stock awards - Stock Titan

Legend (LEGN) Quarterly Update: EPS Exceeds Its Estimate in Latest Trading; Shares After the Report - dars.gov.et

Legend Biotech (NASDAQ:LEGN) Trading Down 5.3% Following Analyst Downgrade - MarketBeat

Oppenheimer downgrades Legend Biotech stock rating on M&A concerns - Investing.com

Oppenheimer downgrades Legend Biotech stock rating on M&A concerns By Investing.com - Investing.com South Africa

Oppenheimer downgrades Legend Biotech stock rating on M&A concerns By Investing.com - Investing.com India

Why is Legend Biotech stock sliding today? - Investing.com

Legend Biotech (LEGN) Q2 2026 Earnings Call Transcript - theglobeandmail.com

Legend Biotech (NASDAQ:LEGN) Shares Gap Up After Strong Earnings - MarketBeat

Why is Legend Biotech stock surging today? By Investing.com - Investing.com South Africa

Legend Biotech Q2 2026 slides: first profitable quarter, 50% growth - Investing.com

Legend Biotech Q2 Earnings Call Highlights - Yahoo Finance

Earnings call transcript: Legend Biotech tops Q2 2026 estimates as stock rises 5% - Investing.com

Why is Legend Biotech stock surging today? - Investing.com

Legend Biotech stock rises 5% on earnings and revenue beat By Investing.com - Investing.com South Africa

Legend Biotech stock rises 5% on earnings and revenue beat By Investing.com - Investing.com India

Legend Biotech stock rises 5% on earnings and revenue beat - Investing.com

Legend Biotech (NASDAQ:LEGN): What Could Today’s Update Reveal About Cell-Therapy Demand And Manufacturing? - Kalkine Media

Legend Biotech Reports Second Quarter 2026 Results and Recent Highlights - Yahoo Finance

Legend Biotech Reports Second Quarter 2026 Results and Recent Highlights - GlobeNewswire

Legend Biotech Reports Second Quarter 2026 Results and Recent Highlights - The Manila Times

Legend Biotech in spotlight: Earnings test Carvykti momentum - Investing.com

Simile a LEGN

EWTX$37.681.13%

ARQT$32.122.75%

TNGX$23.889.74%

ABCL$12.149.13%

DFTX$33.392.82%